Serious risk related to oral use of sodium phosphate solution

Česká verzia

Authors: I. Hoffmanová; M. Anděl
Authors place of work: II. interní klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Michal Anděl, CSc.
Published in the journal: Vnitř Lék 2013; 59(12): 1111-1116
Category: Kazuistika

Summary

Sodium phosphate solutions are commonly used to cleanse the bowel in preparation for colonoscopy, for barium enema or surgical procedures and eventually for treatment of severe constipation. Though relatively safe, these drugs must be used with caution in patients with kidney disease, small intestinal disorders, or poor gut motility and are prohibited in renal insufficiency and bowel obstruction. Especially elderly patients are at increased risk for phosphate intoxication due to decreased glomerular filtration rate, concomitant medication use, and systemic and gastrointestinal diseases. Sodium phosphate solution could induce by at-risk patient’s serious electrolyte abnormalities (hyperphosphatemia, hypocalcemia, hypokalemia) and acute kidney injury caled acute phosphate nephropathy, which is potentially life-threatening condition with slowly progressive renal insufficiency. This article gives a report on two cases of severe adverse effects after administration of oral sodium phosphate solution: an elderly women who developed increase in serum phosphate with compensatory severe hypokalcemia with tetany; and an elderly man who developed acute phosphate nephropathy following colon preparation prior to colonoscopy and barium enema. Especially in elderly and in patients in whom sodium phosphate solution is contraindicated or should be used with caution, we recommend to use isosmotic macrogol (polyethylene glycol) solution for the bowel cleansing a for the treatment of constipation.

Key words:
sodium phosphate solutions – laxative – electrolyte abnormalities – hyperphosphatemia – hypocalcemia – acute phosphate nephropathy – constipation – bowel cleansing

Zdroje

1. Beloosesky Y, Grinblat J, Weiss A et al. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 2003; 163: 803–808.

2. Curran MP, Plosker GL. Oral Sodium Phosphate Solution. A review of its use as a colorectal cleanser. Drugs 2004; 64: 1697–1714.

3. Portalatin M, Winstead N. Medical Management of Constipation. Clin Colon Rectal Surg 2012; 25: 12–19.

4. Hoffmanová I, Janotová D, Havrda M et al. Akutní fosfátová nefropatie po přípravě k vyšetření tlustého střeva natrium-fosfátovým projímadlem. Čes Slov Gastroenterol Hepatol 2008; 62: 264–269.

5. Young CJ, Simpson RR, King DW et al. Oral sodium phosphate solution is a superior colonoscopy preparation to polyethylene glycol with bisacodyl. Dis Colon Rectum 2000; 43: 1568–1571.

6. Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007; 25: 373–384.

7. Markowitz GS, Radhakrishnan J, d’Agati VD. Towards the incidence of acute phosphate nephropathy. J Am Soc Nephrol 2007; 18: 3020–3022.

8. Lien YH. Is Bowel Preparation Before Colonoscopy a Risky Business for The Kidney? Nat Clin Pract Nephrol 2008; 4: 606–614.

9. DiPalma JA, Buckley SE, Warner BA et al. Biochemical effects of oral sodium phosphate. Dig Dis Sci 1996; 41: 749–753.

10. Lochy S, Jacobs R, Honoré PM et al. Phosphate induced crystal acute kidney injury – an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literature. Int J Nephrol Renovasc Dis 2013; 6: 61–64.

11. Fine A, Patterson J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis 1997; 29: 103–105.

12. Tan HL, Liew QY, Loo S et al. Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 2002; 57: 478–483.

13. Stratta P, Barbieri S, Lazzarich E et al. Nephrocalcinosis in phosphate nephropathy following oral phosphate purgative: a role for underlying subclinical primary hyperparathyroidism? Am J Kidney Dis 2007; 50: 1053–1054.

14. Niemeijer ND, Rijk MC, van Guldener C. Symptomatic hypocalcemia after sodium phosphate preparation in an adult with asymptomatic hypoparathyroidism. Eur J Gastroenterol Hepatol 2008; 20: 356–358.

15. Hill AG, Teo W, Still A et al. Cellular potassium depletion predisposes to hypokalaemia after oral sodium phosphate. Aust N Z J Surg 1998; 68: 856–858.

16. Hurst FP, Bohen EM, Osgard EM et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007; 18: 3192–3198.

17. Jacobson RM, Peery J, Thompson WO et al. Serum electrolyte shifts following administration of sodium phosphates enema. Gastroenterol Nurs 2010; 33: 191–201.

18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.

19. Ma RC, Chow CC, Yeung VT et al. Acute renal failure following oral sodium phosphate bowel preparation in diabetes. Diabetes Care 2007; 30: 182–183.

20. FDA Alert 12/11/2008. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126084.htm.

21. Toledo TK, DiPalma JA. Review article: colon cleansing preparation for gastrointestinal procedures. Aliment Pharmacol Ther 2001; 15: 605–611.